PYPD vs QURE

PolyPid Ltd. vs uniQure N.V. — Valuation Comparison 2026

PYPD

Biotechnology
PolyPid Ltd.
Quality
1.8
out of 10
Value Trap
Price
$4.76
Last close
Models
9/13
Active
VS

QURE

Biotechnology
uniQure N.V.
Quality
7.2
out of 10
Value Trap
20
SAFE
Price
$24.85
Last close
Models
11/13
Active

Model-by-Model Comparison

ModelType PYPD Fair ValuePYPD Upside QURE Fair ValueQURE Upside
Bayesian DCF Intrinsic $1.26 -73.5% $5.68 -77.1%
Earnings Power Value Intrinsic $17.03 -11.0%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $26.22 +450.9% $1.63 -93.4%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for PYPD vs QURE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PYPD vs QURE — Which Stock Is More Undervalued?

QURE scores higher with a 7.2/10 quality rating vs PYPD's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing PolyPid Ltd. (PYPD) and uniQure N.V. (QURE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PYPD currently trades at $4.76 with a QOC of 1.8/10, while QURE trades at $24.85 with a QOC of 7.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).